Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 26, 717–718 (1 July 2008) | doi:10.1038/nbt0708-717
|[euro]|2 billion IMI launched with European pharma
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
